Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus.
By M. Stahl, M. Stuschke, N. Lehmann, H. Meyer, M. Walz, S. Seeber, B. Klump, W. Budach, R. Teichmann, Marcus Schmitt and 3 more. Journal of Clinical Oncology, 2005
1,264 citations recorded by the source corpus.
Subfields: Pulmonary and Respiratory Medicine, Surgery
View Paper: https://www.semanticscholar.org/paper/1fa0ba0bd1108f7a8ee89eb447e350e6d3d1cb77
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
- Florian Lordick
- C. Mariette
- K. Haustermans
- R. Obermannova
- D. Arnold
- T. Conroy
- O. Bouché
- P. Michel
Citations in the corpus
- Chemoradiation followed by surgery compared with chemoradiation alone in squamous cancer of the esophagus: FFCD 9102. (2007, positive): “If the patients responding to induction chemotherapy were considered, 3-year survival rates were 58% and 55% in the surgery and no surgery groups, respectively.(17) In the FFCD 9102 study, random as-”
- Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. (2013, background): “In cases of response to neoadjuvant chemo(radio)therapy (40– 50 Gy), further continuation of chemoradiation resulted in equivalent overall survival compared with surgery, albeit that the non-operative strategy was associated with higher local tumour recurrence [16, 17].”